AMGN - AMGEN INC
333.96
2.470 0.740%
Share volume: 833,663
Last Updated: 12-24-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$331.49
2.47
0.01%
Summary score
63%
Profitability
83%
Dept financing
43%
Liquidity
37%
Performance
53%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
28.34%
Return on assets
3.06%
Return on sales
28.09%
Return on invested capital
6.42%
Total debt ratio
93.19%
Debt ratio change over timeo
12.76%
Current Ratio
1.69%
Quick Ratio
1.35%
Cash Position Ratio
0.79%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
3.09%
Return on sales
23.81%
Return on invested capital
0%
Total debt ratio
91.88%
Debt ratio change over timeo
0%
Current Ratio
1.25%
Quick Ratio
0.95%
Cash Position Ratio
0.43%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
5.11%
Return on sales
26.43%
Return on invested capital
0%
Total debt ratio
89.33%
Debt ratio change over time
0%
Current Ratio
1.28%
Quick Ratio
0.99%
Cash Position Ratio
0.43%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
287.7%
Return on assets
-48.3%
Return on sales
443.28%
Return on invested capital
-12.23%
Total debt ratio
1276.22%
Debt ratio change over time
12.76%
Current Ratio
21.08%
Quick Ratio
16.12%
Cash Position Ratio
7.46%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AMGN | GILD | BNTX | BIIB |
|---|---|---|---|---|
| Return on equity | 28.34% | 5.51% | 8.19% | 6.15% |
| Return on assets | 3.06% | 3.18% | 8.03% | 2.21% |
| Return on sales | 28.09% | 27.06% | -13.21% | 23.01% |
| Return on invested capital | 6.42% | 3.22% | -37.31% | 6.7% |
| Profitability | 83% | 51% | 32% | 58% |
| Total debt ratio | 93.19% | 66.22% | 15.12% | 44.66% |
| Debt ratio change over time | 12.76% | 169.64% | -1.03% | 13.01% |
| Dept financing | 27% | 43% | 4% | 14% |
| Current Ratio | 1.25% | 1.43% | 0% | 2% |
| Quick Ratio | 0.95% | 1.29% | 0% | 1.44% |
| Cash Position Ratio | 0.43% | 0.63% | 0% | 0.74% |
| Liquididy | 14% | 11% | 75% | 16% |
| Short-term ratios | AMGN | GILD | BNTX | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 3.09% | 4.74% | 0% | 1.98% |
| Return on sales | 23.81% | 35.93% | 0% | 22.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 83% | 50% | 0% | 26% |
| Total debt ratio | 91.88% | 65.29% | 0% | 38.81% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 18% | 0% | 11% |
| Current Ratio | 1.25% | 1.43% | 0% | 2% |
| Quick Ratio | 0.95% | 1.29% | 0% | 1.44% |
| Cash Position Ratio | 0.43% | 0.63% | 0% | 0.74% |
| Liquididy | 47% | 62% | 0% | 75% |